Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Gastric Cancer

  Free Subscription

Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 23 articles:
HTML format

Single Articles

    May 2022
  1. MA N, Qiao H, Tao H, Gan X, et al
    Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients.
    Clin Res Hepatol Gastroenterol. 2022 May 27:101962.
    PubMed     Abstract available

  2. SIRMAI L, Benusiglio PR, Svrcek M, Dray X, et al
    Magnifying chromoendoscopy with targeted biopsies of intramucosal signet cell adenocarcinomas in a CDH1 pathogenic variant asymptomatic carrier.
    Clin Res Hepatol Gastroenterol. 2022;46:101914.

    April 2022
  3. CARBONI F, Zazza S, Bertini L, Diodoro MG, et al
    Remarkable survival of operated stage IV gastric cancer with resected late isolated colon metastasis.
    Clin Res Hepatol Gastroenterol. 2022 Apr 7:101917.
    PubMed     Abstract available

  4. NG HI, Li ZQ, Zhang YM, Hu CF, et al
    Gastric inverted hyperplastic polyp, an exceptional case diagnosed after endoscopic submucosal dissection.
    Clin Res Hepatol Gastroenterol. 2022;46:101890.
    PubMed     Abstract available

    March 2022
  5. HE T, Yu D, Wang Z, Guo C, et al
    Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: a long-term follow-up study.
    Clin Res Hepatol Gastroenterol. 2022 Mar 25:101913.
    PubMed     Abstract available

  6. LI J, Huang WF, Zhang JY
    A rare case of duodenal neuroendocrine tumor with hepatic metastasis.
    Clin Res Hepatol Gastroenterol. 2022;46:101850.

  7. JENVRIN A, Lepine C, Bozec PL, Taieb J, et al
    Atypical cutaneous metastases of poorly cohesive carcinoma of the stomach: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2022;46:101795.

    October 2021
  8. TAJA-CHAYEB L, Vidal-Millan S, Trejo-Becerril C, Perez-Cardenas E, et al
    Hereditary Diffuse Gastric Cancer (HDGC). An overview.
    Clin Res Hepatol Gastroenterol. 2021 Oct 14:101820.
    PubMed     Abstract available

    September 2021
  9. BOEKEN T, Gallois C, Douard R, Meatchi T, et al
    Bridge to surgery after irinotecan-based liver chemoembolization for metastatic gastric adenocarcinoma: Letter to the editor.
    Clin Res Hepatol Gastroenterol. 2021;45:101557.

    July 2021
  10. LIU H, Liu M, He B, Li Q, et al
    Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways.
    Clin Res Hepatol Gastroenterol. 2021 Jul 28:101779.
    PubMed     Abstract available

  11. TRAN-MINH ML, Lehmann-Che J, Lambert J, Theou-Anton N, et al
    Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01.
    Clin Res Hepatol Gastroenterol. 2021;45:101691.
    PubMed     Abstract available

    June 2021
  12. HOU B, Wang P, Liu T, Chen S, et al
    Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors.
    Clin Res Hepatol Gastroenterol. 2021 Jun 25:101748.
    PubMed     Abstract available

    May 2021
  13. DOUMBE-MANDENGUE P, Beuvon F, Belle A, Dermine S, et al
    Outcomes of endoscopic submucosal dissection for early esophageal and gastric cardia adenocarcinomas.
    Clin Res Hepatol Gastroenterol. 2021;45:101700.
    PubMed     Abstract available

    March 2021
  14. BU X, Chen Z, Zhang A, Zhang X, et al
    Circular RNA CircAFF2 Accelerates Gastric Cancer Development by Activating MiR-6894-5p and Regulating ANTXR 1 Expression.
    Clin Res Hepatol Gastroenterol. 2021 Mar 12:101671.
    PubMed     Abstract available

  15. JIN P, Ji X, Ma S, Kang W, et al
    Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node.
    Clin Res Hepatol Gastroenterol. 2021;45:101634.
    PubMed     Abstract available

    January 2021
  16. CARBONE R, Vanoli A, Rovedatti L, Lucioni M, et al
    Epstein-Barr virus negative smooth muscle neoplasm of the stomach in a young woman.
    Clin Res Hepatol Gastroenterol. 2021;45:101471.
    PubMed     Abstract available

    November 2020
  17. YAN XL, Luo QY, Zhou SN, Pan WT, et al
    MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
    Clin Res Hepatol Gastroenterol. 2020 Nov 30:101574.
    PubMed     Abstract available

  18. LU J, Ma Y, Zhao Z
    MiR-142 suppresses progression of gastric carcinoma via directly targeting LRP8.
    Clin Res Hepatol Gastroenterol. 2020 Nov 29:101520.
    PubMed     Abstract available

    June 2020
  19. LI Z, Xu D, Tong X, Shan C, et al
    Inhibition of beta-glucosidase overcomes gastric cancer chemoresistance through inducing lysosomal dysfunction.
    Clin Res Hepatol Gastroenterol. 2020 Jun 4. pii: S2210-7401(20)30149.
    PubMed     Abstract available

  20. ZHAO E, Zhou C, Chen S
    Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
    Clin Res Hepatol Gastroenterol. 2020 Jun 3. pii: S2210-7401(20)30148.
    PubMed     Abstract available

  21. ZHAO B, Lu H, Luo R, Bao S, et al
    Different clinicopathologic features and prognostic significance of signet ring cell histology in early and locally advanced gastric cancer patients.
    Clin Res Hepatol Gastroenterol. 2020 Jun 3. pii: S2210-7401(20)30147.
    PubMed     Abstract available

    March 2020
  22. JIN P, Ji X, Tian Y
    Surgical management of oligometastatic disease in gastric cancer.
    Clin Res Hepatol Gastroenterol. 2020 Mar 5. pii: S2210-7401(20)30036.
    PubMed     Abstract available

    February 2020
  23. ZHAO B, Mei D, Luo R, Lu H, et al
    Clinicopathological features, risk of lymph node metastasis and survival outcome of synchronous multiple early gastric cancer.
    Clin Res Hepatol Gastroenterol. 2020 Feb 28. pii: S2210-7401(20)30037.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.